Skip to main content

Find Clinical Trials

Home
Conditions
Neurotoxicity

Clinical trial condition

Neurotoxicity

Explore clinical trials studying Neurotoxicity. Study availability and eligibility vary by location and protocol.

55 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Neurotoxicity trial results

Completed

Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel

NCT00003569

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +40 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

NCT00078845

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +44 more
Locations: CCOP - Central Illinois Decatur, Illinois, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

CCOP - Wichita Wichita, Kansas, United States

Christus St. Frances Cabrini Center for Cancer Care Alexandria, Louisiana, United States

View all 15 locations

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer

NCT00003072

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +31 more
Locations: Oncology Service of San Francisco General Hospital Medical Center San Francisco, California, United States

UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States

UCSF/Mt. Zion Cancer Center San Francisco, California, United States

Veterans Affairs Medical Center - San Francisco San Francisco, California, United States

View Trial Details

Completed

Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors

NCT00263861

Conditions: Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +3 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer

NCT00281853

Conditions: Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +3 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details